Qingsong Health (02661): Stabilization Period Concludes with No Price-Stabilizing Actions and Over-Allotment Option Lapses

Stock News
01/18

The stabilization period in relation to the global offering concluded on January 17, 2026 (Saturday), which was the 30th day after the deadline for submitting applications under the Hong Kong public offering.

Since there was no over-allocation in the international offering, the sponsor and overall coordinator (for itself and on behalf of the international underwriters) did not exercise the over-allotment option, and the stabilizing manager or any person acting on its behalf did not undertake any stabilizing actions during the stabilization period.

The over-allotment option lapsed on January 17, 2026 (Saturday), the 30th day following the deadline for submitting Hong Kong public offering applications.

Consequently, no shares have been or will be issued pursuant to the over-allotment option.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10